VeriMommagnolia officinalis bark extract hamilelikte güvenli mi?
No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
Pregnancy-safe products containing magnolia officinalis bark extract
Related ingredients
Frequently asked questions
- magnolia officinalis bark extract hamilelikte güvenli mi?
- No EU Annex II/III listing or harmonised CLP (H360/H361/H340/H350) was found for Magnolia officinalis bark extract; ECHA substance page lists the substance but does not show a harmonised reproductive/CMR classification. Animal/subchronic toxicity studies report effects at high oral doses but do not provide clear developmental/teratogenic evidence, and authoritative cosmetic safety bodies (CIR/SCCS) specific opinions were not found. Topical cosmetic exposure is expected to produce low but measurable systemic absorption for botanical extracts. (Sources: ECHA substance page; rat subchronic toxicity study; product/COSING listings; EWG summary).
- magnolia officinalis bark extract emzirirken güvenli mi?
- No harmonised reproductive/breastfeeding hazard classification or EU cosmetic ban/restriction was identified. Human data on passage into breast milk are not available; animal studies at high oral doses show organ effects but do not document lactation-specific transfer. Topical use could result in low systemic exposure; therefore risk from topical cosmetic use is expected to be low but incompletely characterised. (Sources: ECHA; PubMed toxicity reviews; WebMD/CanABaby summaries).
- magnolia officinalis bark extract bebek cildi için güvenli mi?
- Hazard and mechanism scores unchanged (no evidence of reproductive/developmental or endocrine-disrupting classification). Exposure score increased by +1 for infants because topical botanical extracts can be absorbed more on immature infant skin; therefore if adult topical exposure is low-measurable (1), infant exposure is moderate (2). No infant-specific dermal toxicity or developmental studies were located. (Sources: ECHA; infant-safety summaries; topical absorption rationale).
- VeriMom magnolia officinalis bark extract nasıl puanlıyor?
- VeriMom magnolia officinalis bark extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte magnolia officinalis bark extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.